Joe
07-23-2007, 11:30 PM
ARIUS Research Inc has announced that the Company has initiated the first study in the formal pre-clinical toxicology program for its lead anti-CD44 drug candidate, which is under development for the treatment of breast, prostate and liver cancers.
More... (http://www.news-medical.net/?id=27904)
More... (http://www.news-medical.net/?id=27904)